Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agilent Technologies (NY:A)

137.89 -0.68 (-0.49%)
Official Closing Price Updated: 4:01 PM EDT, Jul 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Agilent Technologies

< Previous 1 2
...
22 23 24 25 26 27 28 29 Next >
News headline image
Following Rough Year, Is Burning Rock Set To Turn The Corner? ↗
Key Takeaways: Burning Rock expects fourth-quarter revenue to grow just 6% year-on-year due to latest Covid-related travel restrictions in China Cancer testing specialist’s... 
Via Benzinga
News headline image
A Look Into Agilent's Debt ↗
Over the past three months, shares of Agilent Technologies (NYSE:A) moved lower by 5.02%. Before having a look at the importance of debt, let us look at how much debt... 
Via Benzinga
News headline image
A Look Into Agilent's Price Over Earnings ↗
In the current session, Agilent Technologies Inc. (NYSE:A) is trading at $162.09, after a 0.34% gain. Over the past month, the stock increased by 3.28%, and in the past... 
Via Benzinga
News headline image
Agilent Increases Cash Dividend to 21 Cents Per Share
From Agilent Technologies, Inc.
Via Business Wire
News headline image
3 New ProShares ETFs Built for the Trends of the Future ↗
Here are three new ETFs focused on future industries to research further as you decide where to invest your hard-earned wealth. 
Via InvestorPlace
News headline image
Analyst Ratings For Asana ↗
Over the past 3 months, 6 analysts have published their opinion on Asana (NYSE:A... 
Via Benzinga
News headline image
Analyst Ratings For Autoliv ↗
Over the past 3 months, 7 analysts have published their opinion on Autoliv (NYSE:A... 
Via Benzinga
News headline image
Agilent Names John Palma to Lead Global Medical Affairs Organization
From Agilent Technologies, Inc.
Via Business Wire
News headline image
Agilent Announces New Ion Mobility LC/Q-TOF and Enhanced Solutions for Biotherapeutics at ASMS 2021
From Agilent Technologies Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc... 
Via Benzinga
News headline image
Expert Ratings For Asana ↗
Over the past 3 months, 9 analysts have published their opinion on Asana (NYSE:A... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Friday ↗
Oppenheimer boosted the price target on Apple Inc. (NASDAQ:A... 
Via Benzinga
News headline image
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
From Agilent Technologies Inc.
Via Business Wire
News headline image
Agilent to Webcast Fourth-Quarter Fiscal Year 2021 Financial Results Presentation
From Agilent Technologies Inc.
Via Business Wire
News headline image
Agilent Commits to Net-Zero Greenhouse Gas Emissions by 2050
From Agilent Technologies, Inc.
Via Business Wire
News headline image
Agilent Gets An A ↗
Revenue is expected to grow 16.50% this year and another 6.60% next year. Earnings are estimated to increase 26.20% this year, an additional 11.80% next year. 
Via Talk Markets
News headline image
ECLUSIVE: Agilent Commits to Net-Zero Greenhouse Gas Emissions By 2050 ↗
Agilent Technologies Inc (NYSE: A) has committed to achieving net-zero greenhouse gas emissions no later than 2050. Agilent has also committed to interim greenhouse gas reduction... 
Via Benzinga
Topics Emissions
News headline image
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
From Agilent Technologies Inc.
Via Business Wire
News headline image
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
From Agilent Technologies Inc.
Via Business Wire
News headline image
Where Ameren Stands With Analysts ↗
Over the past 3 months, 6 analysts have published their opinion on Ameren (NYSE:A... 
Via Benzinga
News headline image
Agilent Announces Thought Leader Award to Bernhard Lendl at the TU Wien (Vienna)
From Agilent Technologies Inc.
Via Business Wire
News headline image
Dr. Mikael Dolsten Named to Agilent Board of Directors
From Agilent Technologies, Inc.
Via Business Wire
News headline image
Agilent Announces Cash Dividend of 19.4 Cents per Share
From Agilent Technologies, Inc.
Via Business Wire
News headline image
A Look Into Agilent's Price Over Earnings ↗
In the current session, Agilent Technologies Inc. (NYSE:A) is trading at $176.22, after a 1.70% gain. Over the past month, the stock increased by 4.81%, and in the... 
Via Benzinga
News headline image
What 6 Analyst Ratings Have To Say About Autoliv ↗
Over the past 3 months, 6 analysts have published their opinion on Autoliv (NYSE:A... 
Via Benzinga
News headline image
Agilent Announces Thought Leader Award to David R. Liu at the Broad Institute
From Agilent Technologies Inc.
Via Business Wire
News headline image
Sphere 3D Shares Dive On Discounted Equity Offering To Fund Crypto Mining ↗
Data management firm Sphere 3D Corp (NASDAQ:A... 
Via Benzinga
News headline image
Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement
From Agilent Technologies Inc.
Via Business Wire
News headline image
Agilent to Present at Wells Fargo Virtual Healthcare Conference
From Agilent Technologies Inc.
Via Business Wire
News headline image
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer
From Agilent Technologies Inc.
Via Business Wire
< Previous 1 2
...
22 23 24 25 26 27 28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.